Developer docs
API playgroundTry for free, no card

Search company profiles

Fluorogenics

Full company profile

uuid002bfwm

Namestring
Fluorogenics
Legal namestring
New England Biolabs, Inc.
Company typeenum
Private
Founded yearint
1970
Descriptiontext

New England Biolabs, Inc. (NEB) operates a specialized lyophilization sciences business that develops and manufactures freeze-dried molecular biology reagents and offers custom lyophilization services. The company's core technology combines over 50 years of proprietary enzyme formulation expertise with lyophilization process optimization, producing ready-to-use reagents that eliminate cold-chain storage requirements and enable room-temperature transport and field deployment. Product lines include LyoPrime Luna Probe One-Step RT-qPCR Mix with UDG, LyoPrime WarmStart Fluorescent LAMP/RT-LAMP Mix with UDG, Monarch DNase I Lyophilized, and a suite of glycerol-free enzymes (Bst-XT WarmStart, Bst 2.0 WarmStart, WarmStart RTx) engineered for lyophilization compatibility. Under the Lyophilization Sciences sub-brand, NEB also provides end-to-end custom formulation, freeze-drying, and packaging services for customer-proprietary assays and third-party reagents.

The company targets three primary customer segments: diagnostic assay developers building point-of-care, point-of-use, and field-deployable molecular tests (the lead segment); academic and industrial life science researchers requiring stable enzyme reagents; and biopharmaceutical manufacturers requiring GMP-grade lyophilized products. Revenue is generated through catalog product sales via the neb.com online store (with free shipping over $450) and higher-value custom lyophilization engagements routed through a dedicated Customized Solutions team. Distribution combines direct online ordering, regional subsidiaries in the US, Canada, UK, Germany, and France, and authorized distributors across Asia-Pacific including China, India, Japan, Korea, Singapore, Australia, and New Zealand.

NEB is a privately held Certified B Corporation founded in 1970 and headquartered at 240 County Road, Ipswich, Massachusetts. The lyophilization business operates within NEB's broader life science tools portfolio spanning restriction enzymes, PCR/qPCR reagents, NGS library prep, CRISPR, protein expression, and nucleic acid purification. Marketing channels include the NEBinspired Blog, NEBTV webinar series, video library, and application notes/whitepapers aimed at technical and scientific buyers. The company holds ISO 9001 certification and operates GMP-grade manufacturing capabilities for regulated supply.

Short descriptiontext

New England Biolabs' Lyophilization Sciences division develops ready-to-use lyophilized molecular biology reagents and offers custom freeze-drying services for diagnostic assay developers, life science researchers, and biopharmaceutical manufacturers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSalisbury, United Kingdom
HQ citystring
Salisbury
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
lyophilized reagents, molecular diagnostics, freeze-drying services, RT-qPCR mixes, custom formulation
Industry2 codes
1Lyophilization (Freeze-Drying) CDMO
CodeHLAGABAIPrimaryYes
2mRNA/LNP & Nucleic Acid Therapeutics CDMO
CodeHLAGABAFPrimaryNo
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Lyophilized Molecular Biology Reagents
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Ready-to-Use Lyophilized Products
TypeOne Time License
Description

Sale of pre-formulated, ready-to-use lyophilized reagents including RT-qPCR mixes, LAMP mixes, and DNase I products

neb.com
2Glycerol-free Reagents
TypeOne Time License
Description

Sale of specialty reagents formulated without glycerol for lyophilization compatibility

neb.com
3Custom Lyophilization Services
TypeProfessional Services
Description

Custom formulation and lyophilization of customer formulations with flexible packaging and format options

neb.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details1 tier
1Standard lyophilized products available for online ordering
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Free shipping for orders over $450. Standard product catalog pricing.

neb.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Lyophilization Sciences
Description

NEB's specialized division offering lyophilization and freeze-drying solutions for temperature-sensitive reagents and assays.

neb.com
Core offering1 text field

Fluorogenics develops, manufactures, and sells lyophilized (freeze-dried) molecular biology reagents — including ready-to-use RT-qPCR mixes, LAMP/RT-LAMP mixes, lyophilized DNase I, and glycerol-free enzymes — designed for ambient-temperature shipping and storage. The company also offers custom lyophilization services for clients who need to convert their own temperature-sensitive assays and reagents into stabilized, room-temperature-stable formats for diagnostic, research, and biopharmaceutical applications.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

NEB's lyophilization solutions encompass ready-to-use lyophilized products, glycerol-free and lyo-compatible reagents, and custom lyophilization services. The product portfolio includes LyoPrime Luna® Probe One-Step RT-qPCR Mix with UDG for RNA detection, LyoPrime WarmStart™ Fluorescent LAMP/RT-LAMP Mix for isothermal amplification, and Monarch® DNase I Lyophilized for nucleic acid workflows. Supporting reagents include Bst-XT WarmStart™ DNA Polymerase, Bst 2.0 WarmStart® DNA Polymerase, and WarmStart® RTx Reverse Transcriptase in glycerol-free formulations. Custom Lyophilization Services enable bespoke formulation development for third-party reagents and proprietary assays.

Product and service1 record
1LyoPrime Luna Probe One-Step RT-qPCR Mix with UDG
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Patheon is a major CDMO within Thermo Fisher Scientific offering commercial-scale lyophilization services for both small molecule and biologic drug products. Competes directly with NEB's custom lyophilization services for biopharmaceutical customers needing GMP-grade freeze-drying.

TypeBroad incumbent
Description

Eurofins is a global bioanalytical services and CDMO network serving pharma, diagnostics, and food/feed. Overlaps with NEB's custom services and biological reagent footprint, though with a much broader service portfolio and different geographic mix.

TypeEmerging player
Description

BioLife Solutions provides biopreservation and cold-chain tools for cell and gene therapies. While not a direct lyophilization CDMO, it addresses the same temperature-sensitive reagent/cell stability problem through alternative preservation technologies, making it a thematic competitor.

TypeDirect peer
Description

Catalent is a global CDMO with substantial lyophilization capacity for biopharmaceuticals, vaccines, and diagnostics reagents. Directly comparable to NEB's custom lyophilization offering, particularly for diagnostic and biopharma clients needing GMP fill-finish.

TypeBroad incumbent
Description

Through its Life Sciences Solutions and Patheon CDMO segments, Thermo Fisher offers broad molecular biology reagents, diagnostic enzymes, and lyophilization services. Overlaps with NEB's reagent catalog and CDMO offerings, but at much larger scale and broader portfolio.

TypeDirect peer
Description

Recipharm is a European CDMO offering lyophilization among its fill-finish services for biologics and small molecules. Comparable to NEB for biopharma and diagnostic GMP-grade lyophilization projects.

TypeDirect peer
Description

Vetter specializes in aseptic fill-finish including lyophilization for injectable biologics and complex compounds. Overlaps with NEB's GMP-grade lyophilization services for biopharma and high-value diagnostic applications.

TypeDirect peer
Description

A specialized contract lyophilization CDMO providing development, scale-up, and commercial lyophilization services. Closely comparable to NEB's custom lyophilization service line for pharma, biotech, and diagnostic customers.

TypeEmerging player
Description

Halo Labs develops formulation and analytical tools for biologic drug development, with overlap into lyophilized and stable biologic formulations. Comparable as an emerging participant in the formulation/lyophilization enablement space.

TypeBroad incumbent
Description

MilliporeSigma supplies a wide range of molecular biology reagents, buffers, and bioprocessing products, including some lyophilized formats. Competes in the broader reagent catalog and offers contract biomanufacturing services that intersect with NEB's custom lyophilization.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Fluorogenics

Lyophilized Molecular Biology Reagentsfluorogenics.co.uk

New England Biolabs' Lyophilization Sciences division develops ready-to-use lyophilized molecular biology reagents and offers custom freeze-drying services for diagnostic assay developers, life science researchers, and biopharmaceutical manufacturers globally.

What Fluorogenics does

New England Biolabs, Inc. (NEB) operates a specialized lyophilization sciences business that develops and manufactures freeze-dried molecular biology reagents and offers custom lyophilization services. The company's core technology combines over 50 years of proprietary enzyme formulation expertise with lyophilization process optimization, producing ready-to-use reagents that eliminate cold-chain storage requirements and enable room-temperature transport and field deployment. Product lines include LyoPrime Luna Probe One-Step RT-qPCR Mix with UDG, LyoPrime WarmStart Fluorescent LAMP/RT-LAMP Mix with UDG, Monarch DNase I Lyophilized, and a suite of glycerol-free enzymes (Bst-XT WarmStart, Bst 2.0 WarmStart, WarmStart RTx) engineered for lyophilization compatibility. Under the Lyophilization Sciences sub-brand, NEB also provides end-to-end custom formulation, freeze-drying, and packaging services for customer-proprietary assays and third-party reagents.

The company targets three primary customer segments: diagnostic assay developers building point-of-care, point-of-use, and field-deployable molecular tests (the lead segment); academic and industrial life science researchers requiring stable enzyme reagents; and biopharmaceutical manufacturers requiring GMP-grade lyophilized products. Revenue is generated through catalog product sales via the neb.com online store (with free shipping over $450) and higher-value custom lyophilization engagements routed through a dedicated Customized Solutions team. Distribution combines direct online ordering, regional subsidiaries in the US, Canada, UK, Germany, and France, and authorized distributors across Asia-Pacific including China, India, Japan, Korea, Singapore, Australia, and New Zealand.

NEB is a privately held Certified B Corporation founded in 1970 and headquartered at 240 County Road, Ipswich, Massachusetts. The lyophilization business operates within NEB's broader life science tools portfolio spanning restriction enzymes, PCR/qPCR reagents, NGS library prep, CRISPR, protein expression, and nucleic acid purification. Marketing channels include the NEBinspired Blog, NEBTV webinar series, video library, and application notes/whitepapers aimed at technical and scientific buyers. The company holds ISO 9001 certification and operates GMP-grade manufacturing capabilities for regulated supply.

Fluorogenics firmographics

Firmographics
Name
Fluorogenics
Legal name
New England Biolabs, Inc.
Website
https://fluorogenics.co.uk
Company type
Private
Founded year
1970
Operating status
Operating
Headcount range
1–10 employees
Short description
New England Biolabs' Lyophilization Sciences division develops ready-to-use lyophilized molecular biology reagents and offers custom freeze-drying services for diagnostic assay developers, life science researchers, and biopharmaceutical manufacturers globally.
Ownership category
akta.pro rank

Fluorogenics industry classification

Industry
Product category
Lyophilized Molecular Biology Reagents
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Lyophilization (Freeze-Drying) CDMO (HLAGABAI)
akta.pro secondary industry
mRNA/LNP & Nucleic Acid Therapeutics CDMO (HLAGABAF)

Keywords

  • Lyophilized reagents
  • Molecular diagnostics
  • Freeze-drying services
  • RT-qPCR mixes
  • Custom formulation

Where Fluorogenics is headquartered

Location

Headquarters

HQ city
Salisbury
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Fluorogenics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Ready-to-Use Lyophilized Products: Sale of pre-formulated, ready-to-use lyophilized reagents including RT-qPCR mixes, LAMP mixes, and DNase I products
  2. Glycerol-free Reagents: Sale of specialty reagents formulated without glycerol for lyophilization compatibility
  3. Custom Lyophilization Services: Custom formulation and lyophilization of customer formulations with flexible packaging and format options

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard lyophilized products available for online ordering

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Fluorogenics product offering

Product offering

Core offering

Fluorogenics develops, manufactures, and sells lyophilized (freeze-dried) molecular biology reagents — including ready-to-use RT-qPCR mixes, LAMP/RT-LAMP mixes, lyophilized DNase I, and glycerol-free enzymes — designed for ambient-temperature shipping and storage. The company also offers custom lyophilization services for clients who need to convert their own temperature-sensitive assays and reagents into stabilized, room-temperature-stable formats for diagnostic, research, and biopharmaceutical applications.

Product overview

NEB's lyophilization solutions encompass ready-to-use lyophilized products, glycerol-free and lyo-compatible reagents, and custom lyophilization services. The product portfolio includes LyoPrime Luna® Probe One-Step RT-qPCR Mix with UDG for RNA detection, LyoPrime WarmStart™ Fluorescent LAMP/RT-LAMP Mix for isothermal amplification, and Monarch® DNase I Lyophilized for nucleic acid workflows. Supporting reagents include Bst-XT WarmStart™ DNA Polymerase, Bst 2.0 WarmStart® DNA Polymerase, and WarmStart® RTx Reverse Transcriptase in glycerol-free formulations. Custom Lyophilization Services enable bespoke formulation development for third-party reagents and proprietary assays.

Differentiator

Problem solved

Functional benefit

Brands

  • Lyophilization Sciences: NEB's specialized division offering lyophilization and freeze-drying solutions for temperature-sensitive reagents and assays.

Products and services

  • LyoPrime Luna Probe One-Step RT-qPCR Mix with UDG

Companies that use Fluorogenics

Customer profile

Segments3 records

Ideal customer profiles3 records

Fluorogenics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Fluorogenics partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Fluorogenics competitors and assessment

Company assessment

Direct peers

  • Patheon (Thermo Fisher Scientific): Patheon is a major CDMO within Thermo Fisher Scientific offering commercial-scale lyophilization services for both small molecule and biologic drug products. Competes directly with NEB's custom lyophilization services for biopharmaceutical customers needing GMP-grade freeze-drying.
  • Catalent: Catalent is a global CDMO with substantial lyophilization capacity for biopharmaceuticals, vaccines, and diagnostics reagents. Directly comparable to NEB's custom lyophilization offering, particularly for diagnostic and biopharma clients needing GMP fill-finish.
  • Recipharm: Recipharm is a European CDMO offering lyophilization among its fill-finish services for biologics and small molecules. Comparable to NEB for biopharma and diagnostic GMP-grade lyophilization projects.
  • Vetter Pharma: Vetter specializes in aseptic fill-finish including lyophilization for injectable biologics and complex compounds. Overlaps with NEB's GMP-grade lyophilization services for biopharma and high-value diagnostic applications.
  • Lyophilization Technology, Inc. A specialized contract lyophilization CDMO providing development, scale-up, and commercial lyophilization services. Closely comparable to NEB's custom lyophilization service line for pharma, biotech, and diagnostic customers.

Broad incumbents

  • Eurofins Scientific: Eurofins is a global bioanalytical services and CDMO network serving pharma, diagnostics, and food/feed. Overlaps with NEB's custom services and biological reagent footprint, though with a much broader service portfolio and different geographic mix.
  • Thermo Fisher Scientific: Through its Life Sciences Solutions and Patheon CDMO segments, Thermo Fisher offers broad molecular biology reagents, diagnostic enzymes, and lyophilization services. Overlaps with NEB's reagent catalog and CDMO offerings, but at much larger scale and broader portfolio.
  • Merck KGaA (MilliporeSigma): MilliporeSigma supplies a wide range of molecular biology reagents, buffers, and bioprocessing products, including some lyophilized formats. Competes in the broader reagent catalog and offers contract biomanufacturing services that intersect with NEB's custom lyophilization.

Emerging players

  • BioLife Solutions: BioLife Solutions provides biopreservation and cold-chain tools for cell and gene therapies. While not a direct lyophilization CDMO, it addresses the same temperature-sensitive reagent/cell stability problem through alternative preservation technologies, making it a thematic competitor.
  • Halo Labs: Halo Labs develops formulation and analytical tools for biologic drug development, with overlap into lyophilized and stable biologic formulations. Comparable as an emerging participant in the formulation/lyophilization enablement space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Fluorogenics social profiles

Digital presence

Fluorogenics compliance and trust

Trust signal

Compliance1 record

Fluorogenics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Fluorogenics leadership team

Management profile

Number of profiles

Fluorogenics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Fluorogenics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fluorogenics

What does Fluorogenics do?

Fluorogenics develops, manufactures, and sells lyophilized (freeze-dried) molecular biology reagents — including ready-to-use RT-qPCR mixes, LAMP/RT-LAMP mixes, lyophilized DNase I, and glycerol-free enzymes — designed for ambient-temperature shipping and storage. The company also offers custom lyophilization services for clients who need to convert their own temperature-sensitive assays and reagents into stabilized, room-temperature-stable formats for diagnostic, research, and biopharmaceutical applications.

Is Fluorogenics a public or private company?

Fluorogenics is a private company. It is classified as unknown and is currently operating.

When was Fluorogenics founded?

Fluorogenics was founded in 1970. It employs 1 to 10 people.

Where is Fluorogenics based?

Fluorogenics is headquartered in Salisbury, United Kingdom, in the Europe region.

How does Fluorogenics make money?

Three revenue lines are on record. Ready-to-Use Lyophilized Products are the primary driver. The others are glycerol-free Reagents and custom Lyophilization Services.

Who are Fluorogenics's main competitors?

Direct peers on record are Patheon (Thermo Fisher Scientific), Catalent, Recipharm, Vetter Pharma and Lyophilization Technology, Inc.. Broad incumbents are Eurofins Scientific, Thermo Fisher Scientific and Merck KGaA (MilliporeSigma). Emerging players are BioLife Solutions and Halo Labs.

Does Fluorogenics have an API?

No public API is recorded for Fluorogenics.

What industry is Fluorogenics in?

Fluorogenics's product category is Lyophilized Molecular Biology Reagents. Its primary akta.pro industry code is HLAGABAI, Lyophilization (Freeze-Drying) CDMO, with a secondary code of HLAGABAF, mRNA/LNP & Nucleic Acid Therapeutics CDMO. Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireNew England Biolabs® Launches LyoPrime Luna™ RT-qPCR Master Mix, the First Lyophilized Product Since its Acquisition of Fluorogenics™New England Biolabs announced the launch of LyoPrime Luna, its first lyophilized product developed following the 2021 acquisition of Fluorogenics. This room temperature-stable RT-qPCR master mix combines NEB's reagent expertise with Fluorogenics' lyophilization technology to offer a stable alternative to liquid formats. The company states this release aims to simplify assay development and reduce environmental impacts associated with cold chain logistics.NebNew England Biolabs® to acquire Fluorogenics LimitedNew England Biolabs, Inc. announced its agreement to acquire Fluorogenics Limited, a UK-based lyophilization R&D service company, making it a wholly-owned subsidiary. This acquisition aims to combine NEB's enzyme manufacturing expertise with FGL's lyophilization capabilities to better serve the molecular diagnostics market. The move is intended to expand NEB's ability to provide robust, ambient-stable reagents for point-of-care diagnostic testing.PR NewswireNew England Biolabs® to acquire Fluorogenics LimitedNew England Biolabs announced its acquisition of Fluorogenics Limited, a UK-based lyophilization R&D service company, to integrate lyophilized reagent capabilities into its product portfolio. This strategic move aims to enhance NEB's offerings in the molecular diagnostics market by combining enzyme manufacturing expertise with ambient-stable storage solutions.